没有ST升高的急性冠状动脉综合征:实施新的指导方针
C W Hamm1, M Bertrand, E Braunwald
1Department of Cardiology, Kerckhoff Heart Center, Benekestrasse 2-8, D-61231 Bad Nauheim, Germany. Christian.Hamm@kerckhoff.med.uni-giessen.de
Lancet (London, England)
|November 14, 2001
概括
针对不稳定性心痛和非ST段升高心肌梗塞的新指导方针包括多波宁和新疗法. 早期的侵入性治疗和克洛皮多格雷尔对高风险患者有进一步的益处.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 不稳定的心痛和非ST段升高的心肌梗塞是冠状动脉疾病的关键表现.
- 欧洲 (ESC) 和美国 (ACC/AHA) 协会最近发布的指导方针涉及诊断,风险分层和治疗.
研究的目的:
- 总结目前的证据和临床实践指南,针对不稳定的心痛和非ST段升高心肌梗塞.
- 突出这些条件的管理中的关键更新和新发现.
主要方法:
- 审查和综合当前的证据和专业社会的指导方针.
- 对影响治疗策略的最新研究结果的分析.
主要成果:
- 现在的指导方针包括热素在风险分层中.
- 低分子量肝素和糖蛋白IIb/IIIa对抗剂被添加到医疗治疗中.
- 侵入性管理在改善长期结果方面发挥着作用.
结论:
- 新出现的证据支持早期的侵入性治疗和高风险患者的克洛皮多格雷尔.
- 专业协会将合作更新和实施修订后的指南.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


